Phase II trial of combination pembrolizumab, olaparib, and temozolomide for patients with recurrent glioma Meeting Abstract
| Authors: | Schaff, L.; Fortunato, J.; Grommes, C.; Gavrilovic, I. T.; Lin, A.; Pentsova, E.; Miller, A.; Newton, A.; Gonzalez, A.; Mellinghoff, I. K.; Kaley, T. J. |
| Abstract Title: | Phase II trial of combination pembrolizumab, olaparib, and temozolomide for patients with recurrent glioma |
| Meeting Title: | 2023 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2023 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-06-01 |
| Language: | English |
| DOI: | 10.1200/JCO.2023.41.16_suppl.TPS2087 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: TPS2087 -- Meeting was also available virtually -- Source: Cinahl |
Altmetric
Citation Impact
BMJ Impact Analytics
